Top Markets
Coin of the day
Skye Bioscience, Inc. Skye Bioscience, Inc.

Skye Bioscience, Inc.

SKYE
Rank in Stocks #31149
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on... Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.
Share Price
$0.38
Market Cap
$13.35M
Change (1 day)
-8.46%
Change (1 year)
-88.79%
Country
US
Trade Skye Bioscience, Inc. (SKYE)

Category

Stock split history for Skye Bioscience, Inc. (SKYE)
Skye Bioscience, Inc. stock (symbol: SKYE) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 18, 2026.
One SKYE share bought prior to Aug 18, 2026 would equal to 0 SKYE shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
BE